{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:05:00Z","timestamp":1789542300195,"version":"build-2803163510"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11739-026-04328-8","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:26:08Z","timestamp":1773937568000},"page":"2355-2356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Euglycemic ketoacidosis in a nondiabetic patient with Duchenne muscular dystrophy on dapagliflozin: comment"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7335-3120","authenticated-orcid":false,"given":"Claudia","family":"St\u00f6llberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Finsterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"4328_CR1","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s11739-025-04058-3","volume":"6","author":"AM Guti\u00e9rrez-Baena","year":"2025","unstructured":"Guti\u00e9rrez-Baena AM, TegidoMateu M, \u00c1lvarez Schlegel P, Clotet-Vidal S (2025) Euglycemic ketoacidosis in a non-diabetic patient with Duchenne muscular dystrophy on dapagliflozin. Intern Emerg Med 6:1865\u20131867. https:\/\/doi.org\/10.1007\/s11739-025-04058-3","journal-title":"Intern Emerg Med"},{"key":"4328_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejim.2025.02.003","volume":"137","author":"C St\u00f6llberger","year":"2025","unstructured":"St\u00f6llberger C, Wilfing R, Finsterer J, Schneider B (2025) Sodium-glucose cotransporter2 inhibitor-associated ketoacidosis in nondiabetic patients. Eur J Intern Med 137:133\u2013136. https:\/\/doi.org\/10.1016\/j.ejim.2025.02.003","journal-title":"Eur J Intern Med"},{"issue":"1","key":"4328_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2337\/dc23-1163","volume":"47","author":"MMGJ Umapathysivam","year":"2024","unstructured":"Umapathysivam MMGJ, Stranks SN, Jesudason D (2024) Euglycemic ketoacidosis in two patients without diabetes after introduction of sodium-glucose cotransporter 2 inhibitor for heart failure with reduced ejection fraction. Diabetes Care 47(1):140\u2013143. https:\/\/doi.org\/10.2337\/dc23-1163","journal-title":"Diabetes Care"},{"issue":"1","key":"4328_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/01.ccm.0000906648.55213.e3","volume":"51","author":"H Sun","year":"2023","unstructured":"Sun H, Paul J, Miller L (2023) 228 postoperative euglycemic ketoacidosis in the setting of SGLT-2 inhibitor use for heart failure. Crit Care Med 51(1):98\u201398 ((Abstract))","journal-title":"Crit Care Med"},{"issue":"3","key":"4328_CR5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ajpath.2025.11.002","volume":"196","author":"C Dostal","year":"2026","unstructured":"Dostal C, Reiner J, Antunes Goncalves AI, Sousa LS, Knapp M, Fischlein J, Marksteiner J, Sauer J, Oudit GY, Wagner A, Abraham D, Hilber K, Kratochwill K, Podesser BK, Kiss A (2026) Targeting skeletal muscle in Duchenne muscular dystrophy: integrating in silico and experimental approaches to sodium-glucose cotransporter-2 inhibition. Am J Pathol 196(3):745\u2013765. https:\/\/doi.org\/10.1016\/j.ajpath.2025.11.002","journal-title":"Am J Pathol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04328-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-026-04328-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04328-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:34:12Z","timestamp":1789540452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-026-04328-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4328"],"URL":"https:\/\/doi.org\/10.1007\/s11739-026-04328-8","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}